Amisulpride in schizophrenia.
作者信息
Reid S, Turner J
出版信息
Br J Psychiatry. 1998 May;172:450. doi: 10.1192/bjp.172.5.450a.
PMID:9747415
Abstract
摘要
相似文献
1
Amisulpride in schizophrenia.氨磺必利治疗精神分裂症
Br J Psychiatry. 1998 May;172:450. doi: 10.1192/bjp.172.5.450a.
2
Clozapine augmentation with amisulpride.氯氮平联合氨磺必利增效治疗
J Psychiatry Neurosci. 2014 Nov;39(6):E38-9. doi: 10.1503/jpn.140094.
3
Focus on amisulpride.关注阿立哌唑。 （注：原文中药物名称有误，正确的是阿立哌唑，而不是amisulpride，amisulpride是氨磺必利）
Curr Med Res Opin. 2002;18(3):113-7. doi: 10.1185/030079902125000363.
4
Switching to amisulpride due to hepatic complications.因肝脏并发症改用氨磺必利。
Eur Psychiatry. 2002 May;17(3):170-1. doi: 10.1016/s0924-9338(02)00641-7.
5
Switching to amisulpride monotherapy for treatment-resistant schizophrenia.换用氨磺必利单药治疗难治性精神分裂症。
Eur Psychiatry. 2006 Apr;21(3):214-7. doi: 10.1016/j.eurpsy.2006.01.013. Epub 2006 Mar 13.
6
Amisulpride and cardiomyopathy.氨磺必利与心肌病
Aust N Z J Psychiatry. 2005 Aug;39(8):738. doi: 10.1080/j.1440-1614.2005.01666_5.x.
7
Amisulpride: its role in the therapeutic management of the schizophrenia patient. Conclusions.氨磺必利：其在精神分裂症患者治疗管理中的作用。结论。
Acta Psychiatr Scand Suppl. 2000;400:28-9.
8
The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study.氨磺必利在中国精神分裂症患者中的有效性和安全性：一项为期8周的前瞻性、开放标签、多中心、单臂研究。
Asia Pac Psychiatry. 2016 Sep;8(3):241-4. doi: 10.1111/appy.12238. Epub 2016 Mar 28.
9
Amisulpride augmentation of clozapine in refractory schizophrenia.
J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):E15. doi: 10.1176/jnp.23.3.jnpe15.
10
[Amisulpride--a neuroleptic agent for all phases of schizophrenia].
Nervenarzt. 1999 Mar;70(3 Suppl Amisulprid):1-8.
Zotero 插件